Valneva SE (VALN) EPS (Basic) (2021 - 2026)
Valneva SE (VALN) posted quarterly EPS (Basic) of -$0.16 for Q1 2026, down 244.46% year-on-year from $0.11 in Q1 2025, and up 52.68% on a QoQ basis from -$0.34 in Q4 2025.
Valneva SE (VALN) EPS (Basic) (2021 - 2026) Analysis & Trends
Valneva SE (VALN) has reported EPS (Basic) for 6 consecutive years, with -$0.16 the latest figure, recorded in Q1 2026.
- Quarterly EPS (Basic) fell 244.46% year-over-year to -$0.16 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.9 (down 89.42% YoY) and the FY2025 annual result came in at -$0.78, down 848.86% from the prior year.
- EPS (Basic) advanced to -$0.16 in Q1 2026 per VALN's latest filing, from -$0.34 in the prior quarter.
- Over the last five years, EPS (Basic) for VALN reached as high as $95.24 in Q3 2022 and fell as low as -$144.84 in Q2 2022.
- A 5-year average of -$3.07 and a median of -$0.18 in 2024 frame the typical range for EPS (Basic).
- The largest YoY upside for EPS (Basic) was 4920.46% in 2022 against a maximum downside of 20300.71% in 2022.
- Year by year, EPS (Basic) stood at -$0.56 in 2022, then surged by 63.18% to -$0.2 in 2023, then surged by 56.57% to -$0.09 in 2024, then sank by 281.59% to -$0.34 in 2025, then soared by 52.68% to -$0.16 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.16, -$0.34, and -$0.38 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn | -0.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.16 |
| Dec 31, 2025 | -0.34 |
| Sep 30, 2025 | -0.38 |
| Jun 30, 2025 | -0.08 |
| Mar 31, 2025 | -0.05 |
| Dec 31, 2024 | -0.09 |
| Sep 30, 2024 | -0.18 |
| Jun 30, 2024 | -0.18 |
| Mar 31, 2024 | 0.56 |
| Dec 31, 2023 | -0.20 |
| Sep 30, 2023 | -0.22 |
| Jun 30, 2023 | -0.18 |
| Mar 31, 2023 | -0.16 |
| Dec 31, 2022 | -0.56 |
| Sep 30, 2022 | 95.24 |
| Jun 30, 2022 | -144.84 |
| Mar 31, 2022 | -0.29 |
| Dec 31, 2021 | 1.97 |
| Sep 30, 2021 | -1.98 |
| Jun 30, 2021 | -0.71 |